Peer Review History
| Original SubmissionApril 9, 2026 |
|---|
|
Dear Dr. Mukerjee, Please submit your revised manuscript by Jun 27 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Arun Kumar Sharma Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: “It is funded by the Indian Council of Medical Research (ICMR) Delhi (Grant No: 5/7/Intramural/Dr_Bijaya_Mishra). Representatives from ICMR contributed to the conceptualization and protocol development and will continue to be part of the study by providing oversight through supervision and monitoring. All data generated from the study will be stored electronically at ICMR, and the institute retains the rights to the data. “ Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: A very important research is being proposed by the authors. This has a potential to help us understand the status, barriers and facilitators of comprehensive abortion care services in rural areas. Being a multi centre study, the results will highlight the scenario of CAC services for the policy makers to improve the services. The authors may respond to following observations: 1.Title: It is a multi center study and not multi centric study. 2. Methods A. Why unmarried women are excluded. The riask of unsafe abortion and barriers to CAC among unmarried women are equally important. B. Legally defined age is 18 to 49 but pregnancy below 18 years is not illegal per se. By excluding the 15-18 age group, in Indian conext, a key and vulnerable beneficiary is getting excluded from the study. C. Sample size: Assuming 50% prevalence across all selected MRHRUs is an untenable value for sample size calculation. In absence of relevant literature, pilot study is undertaken to calculate sample size. If the results show very low prevalnce say < 10% or very high prevalence, say >90%, the sample size estimation will become null and void. D. What is the rationale for design effect of 2? F. In a cross sectional survey , there is no utility of accounting for attrition. G. For qualitative component, age range is described as 15 to 49, contradictng the legal age of 18 to 49 years H. How can multivariable rgression models be generated if there are no a priori hypotheses stated and sample sizes are calculated as per hypotheses? I. How missing data will be handled, should be explained. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: Thank you for your submission. This is a well written protocol for a well planned multi-centric study, which when done well, will provide valuable insights for implementation of the model 0, as stated. Please address the following issues, to make the manuscript a comprehensive read for the audience, so that it may stand alone on its own - 1. Elaborate more on the selection and deployment of data collectors/ interviewers/ moderators for qualitative data collection - what kind of relationship do they share with the community/ what training they have undergone/ what stakeholders they will be engaging with to make them suitable to undertake such sensitive conversations in their respective areas? This may also include their relevant past experience in the same area. 2. How are the live-in relationships in Maharashtra area being defined? Is there a time-based criterion for inclusion, or any criteria? The exception has only been mentioned, not explained. 3. How were the questions for moderator/ facilitator guide(s) for KII and FGDs arrived at? Was the CFIR framework used for the design of the guide(s) as well? What were the key literature findings that guided the choice of questions. 4. It is a good practice in qual research for moderator/ facilitators to reconvene after FGDs to tweak the guide(s) based on their subsequent experiences of FGDs. Some new areas may come up during FGD, which make good addition to the guide for subsequent discussions. While the authors mention maintaining an audit trail throughout the study, it is not clear of the same extends to this specific aspect of refining the tool. Reviewer #2: Manuscript number: PONE-D-26-10674 Reviewer’s Comments: The Comprehensive Abortion Care (CAC) tool from India's National Health Mission is a vital guide for ensuring safe abortion through improved planning and health system requirements. As the authors note, only a few studies demonstrate that expanding facilities is closely linked to increased availability of abortion care services. Given that facility readiness is a critical aspect of successful implementation of CAC service in India and that implementation research plays an important role in adopting evidence-based services in India, this study—utilizing model rural health research units—is highly relevant. We consider this study protocol for publication with some minor revisions to enhance its clarity and contribution. Introduction section The manuscript provides a detailed rationale for generating evidence regarding facility readiness and care-seeking experiences in rural settings. To further strengthen this section: • The authors should highlight the necessity of conducting this mixed-method study as a multi-centre initiative. • To assist an international audience, elaborating on the specific contextual similarities and differences across the various study sites in India will support the rationale. Methods section • The data collection methods are well-documented, and the involvement of multiple stakeholders is a significant strength. Data collection methods has been well explained and documented. Involving multiple stakeholders is an important step. The inclusion of population differences for the Maharashtra study site in the eligibility criteria is noted and appreciated. However, the following points regarding big qualitative data and sampling should be addressed: • Predicting in advance, how much data will be enough is a requirement for a-priori sample size calculation and funding requirements. While it is mentioned that sampling will be guided by thematic saturation, the authors must be aware and mention somewhere in the section on “Qualitative sampling” that recruitment methods will facilitate varied samples and allow for adaptability. • Instead of providing exact numbers for qualitative samples, authors can consider providing a range to better account for the variability across contexts. • Developing a broad coding framework will be helpful as it will avoid redoing the process of in-depth analysis altogether and reduce redundancy. • As the author mentions, that- “the goal is not national prevalence estimation but generation of transferable lessons on service delivery processes and system constraints”, authors should consider analysing variations within and across sites. o There will be site-specific issues- for example, a barrier might be identified in majority of sites. However, the effect of this barrier on implementation might differ across sites. o There will be variations in provider-centered and patient-centered perspectives. How do authors plan to deal with those variations before reaching conclusions, like relying on additional data or observations can be mentioned. • The manuscript currently mentions concurrent analysis of quantitative and qualitative data. Authors should consider adding concurrent data collection and analysis in the manuscript where the authors mention conducting bracketing exercises. Evidence from implementation research underscores the value of this approach, as it facilitates the revising strategies and interview questions to better capture pertinent emerging data. Minor Corrections • Throughout the methodology, the study population is defined as women aged 18–49 years; however, the qualitative sampling section lists the age as 15–49 years. Please clarify the reason for this discrepancy. • The final sentence of the Discussion section appears to be incomplete and requires correction. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Dear Dr. Mukerjee, Please submit your revised manuscript by Oct 03 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS One offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Arun Kumar Sharma Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments : All concerns of the reviewers have been addressed satisfactorily sans one comment of the editor. The design effect is calculated using the formula, assuming equal cluster sizes: 1+(m-1)ρ where m= average number of individuals sampled per cluster. ρ= intracluster correlation coefficient. In case of unequal cluster sizes, following formula is used: design effect=1+[m(1+CV*2)-1]ρ An arbitrary design effect is statistically not tenable. I understand that the project has been approved by ICMR and modifications are not possible. Nonetheless, for the sake of the readers of the journal, it is pertinent to mention how the effect size was determined. Authors may consider explaining that design effect was arbitrary. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: All the reviewer comments have been addressed satisfactorily. The authors have provided a detailed explanation, and comprehensive logs of changes made. Manuscript recommended to proceed for next steps. Reviewer #2: Including the suggestions from the editor and reviewers, the manuscript can now be accepted for publication. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Status, Barriers and Facilitators of Comprehensive Abortion Care Services in rural India: A Multicenter Mixed-Methods Study Protocol PONE-D-26-10674R2 Dear Dr. Mukherjee, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Arun Kumar Sharma Academic Editor PLOS One Additional Editor Comments (optional): The response to the comments is satisfactory. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-26-10674R2 PLOS One Dear Dr. Mukerjee, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS One Editorial Office Staff on behalf of Professor Arun Kumar Sharma Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .